Eric Yvon

1 ta ish

1. Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy

   Andras Heczey, Daofeng Liu, Gengwen Tian +10

   Maqola20144 iqtibos

   ABIABI:AkademIndex/2026.other.340832